David J. Ritchie
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Use and Resistance 16
-
- Antibiotic Resistance in Bacteria 13
- Co-authors
- Scott T. MicekMarin H. KollefRichard M. ReichleyVictoria J. FraserAnn E. LloydThomas C. BaileyPeggy S. McKinnonW. Michael Dunne
- Journals
- Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (10 papers)Clinical Infectious Diseases (5 papers)Clinical Therapeutics (5 papers)Antimicrobial Agents and Chemotherapy (5 papers)Physical Review Letters (4 papers)
- Partner nations
- United StatesAustraliaCyprus
In The Last Decade
David J. Ritchie
67 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 148
- Applied Microbiology and Biotechnology 530
- Molecular Medicine 685
- Clinical Biochemistry 464
- Critical Care and Intensive Care Medicine 282
- Geriatrics and Gerontology 192
Countries citing papers authored by David J. Ritchie
This map shows the geographic impact of David J. Ritchie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Ritchie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Ritchie more than expected).
Fields of papers citing papers by David J. Ritchie
This network shows the impact of papers produced by David J. Ritchie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Ritchie. The network helps show where David J. Ritchie may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David J. Ritchie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2022 | 4 | |
| 3 | 2018 | 14 | |
| 4 | 2016 | 39 | |
| 5 | 2015 | 29 | |
| 6 | 2015 | 39 | |
| 7 | 2013 | 11 | |
| 8 | 2012 | 50 | |
| 9 | 2011 | 18 | |
| 10 | 2007 | 38 | |
| 11 | 2007 | 37 | |
| 12 | 2005 | 14 | |
| 13 | 2004 | 30 | |
| 14 | 2003 | 139 | |
| 15 | 2003 | 38 | |
| 16 | 2003 | 14 | |
| 17 | 2002 | 26 | |
| 18 | 1999 | 155 | |
| 19 | 1995 | 11 | |
| 20 | 1993 | 78 |
About David J. Ritchie
David J. Ritchie is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine, Clinical Biochemistry, Geriatrics and Gerontology and Pharmacology, having authored 68 papers that have together received 2.5k indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (16 papers), Antibiotics Pharmacokinetics and Efficacy (15 papers), Antibiotic Resistance in Bacteria (13 papers), Antimicrobial Resistance in Staphylococcus (9 papers), Bacterial Identification and Susceptibility Testing (9 papers), Particle physics theoretical and experimental studies (7 papers), Pneumonia and Respiratory Infections (7 papers) and High-Energy Particle Collisions Research (5 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (530 citations), Molecular Medicine (685 citations), Clinical Biochemistry (464 citations), Critical Care and Intensive Care Medicine (282 citations) and Geriatrics and Gerontology (192 citations). David J. Ritchie has collaborated with scholars based in United States, Australia and Cyprus. Frequent co-authors include Scott T. Micek, Marin H. Kollef, Richard M. Reichley, Victoria J. Fraser, Ann E. Lloyd, Thomas C. Bailey, Peggy S. McKinnon, W. Michael Dunne, Ed Casabar and Meghan N. Jeffres. Their work appears in journals such as Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, Clinical Infectious Diseases, Clinical Therapeutics, Antimicrobial Agents and Chemotherapy and Physical Review Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.